Clinical Trials

Cluster-based epidemiological assessment in patients admitted to internal medicine with at least one of the following diagnoses: heart failure, chronic obstructive pulmonary disease or renal failure. The InCLuDimi study

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 16 July 2026
0
Views
0
Downloads

Authors

Advances in medical care have increased both the age and clinical complexity of patients admitted to internal medicine wards, with multiple chronic conditions significantly impacting outcomes and treatment...

Downloads

Download data is not yet available.

Citations

Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002;162:2269-76.
National Guideline Centre. Multimorbidity: assessment, prioritisation and management of care for people with commonly occurring multimorbidity. London: National Institute for Health and Care Excellence (NICE); 2016.
Tangianu F, Gnerre P, Colombo F, et al. Could clustering of comorbidities be useful for better defining the internal medicine patients’ complexity? Ital J Med 2018;12:137-44.
Schäfer I, von Leitner EC, Schön G, et al. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One 2010;5:e15941.
Cornell JE, Pugh JA, Williams JW, et al. Multimorbidity clusters: Clustering binary data from a large administrative medical database. Appl Multivar Res 2007;12:163-82.
John R, Kerby DS, Hennessy CH. Patterns and impact of comorbidity and multimorbidity among community-resident American Indian elders. Gerontologist 2003;43:649-660.
Marengoni A, Rizzuto D, Wang HX, et al. Patterns of chronic multimorbidity in the elderly population. J Am Geriatr Soc 2009;57:225-30.
Scott IA, Gray LC, Martin JH, et al. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med 2013;18:121-4.
Whitty CJM, Watt FM. Map clusters of diseases to tackle multimorbidity. Nature 2020;579:494-6.
Para O, Vanetti M, Dibonaventura C, et al. Chronic obstructive pulmonary disease and heart failure in real life: the tip of the iceberg in the sea of comorbidities. A prospective observational study. Monaldi Arch Chest Dis 2026;96:3157.
Bisquera A, Gulliford M, Dodhia H, et al. Identifying longitudinal clusters of multimorbidity in an urban setting: a population-based cross-sectional study. Lancet Reg Health Eur 2021;3:100047.
Mannucci PM, Nobili A, Pasina L, REPOSI Collaborators. Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register. Intern Emerg Med 2018;13:1191-200.
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (esc)developed with the special contribution of the heart failure association (hfa) of the esc. Eur Heart J 2016;37:2129-200.
2021 Global Strategy for Prevention, Diagnosis and Management of COPD; https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf
KDIGO. 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Official Journal of the International Society of Nephrology, Kidney International Supplements 2013. doi:10.1038/kisup.2012.75

How to Cite



Cluster-based epidemiological assessment in patients admitted to internal medicine with at least one of the following diagnoses: heart failure, chronic obstructive pulmonary disease or renal failure. The InCLuDimi study. (2026). Italian Journal of Medicine. https://doi.org/10.4081/itjm.2026.2498